Two patients who were taking warfarin experienced significant prolongations of the prothrombin time (protime) after treatment with high-dose corticosteroids for rapid progression of MS. This complication of therapy is potentially life-threatening.
Corticosteroids. (1996) In: McEvoy G (ed.) American Hospital Formulary Service Drug Information, American Society of Health System Pharmacists, Inc. Bethesda p 2223.
2.
Quinn DI, Day RO (1995) Drug interactions of clinical importance: An updated guide. Drug Safety12: 393 - 452.
3.
Baciewicz AM , Morgan PJ (1990) Ranitidine-warfarin interaction . Ann Intern Med112: 76 - 77 [letter].
4.
Sax MJ (1987) Clinically important adverse effects and drug interactions with H2-receptor antagonists: An update. Pharmacotherapy7: 110S - 115S.
5.
DeLepeleire I. et al. (1990) Lack of interaction between famotidine and warfarin. Int J Clin Pharmacol Res10: 167 - 171.
6.
Derendorf H. et al. (1993) Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids. J Clin Pharmacol33: 115 - 123.
7.
Okabe N., Hashizume N. (1994) Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism. Biol Pharm Bull17: 16-21.
8.
Hulter HN et al. (1980) Effects of glucocorticoid steroids on renal and systemic acid-base metabolism. Am J Physiol239: F30 - 43.
9.
Yun CH et al. (1993) Glucocorticoid stimulation of ileal Na+ absorptive cell brush border Na+/H+ exchange and association with an increase in message NHE-3, and epithelial Na+/H+ exchanger isoform. J Biol Chem268: 206-211.
10.
Seldin DW, Rector FC Jr. (1972) The generation and maintenance of metabolic alkalosis . Kidney Int1: 306- 321.
